Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_assertion type Assertion NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_head.
- NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_assertion wasGeneratedBy ECO_0000203 NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_provenance.
- NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_assertion wasDerivedFrom befree-2016 NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_provenance.
- NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_assertion SIO_000772 20595063 NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_provenance.
- NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_assertion evidence source_evidence_literature NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_provenance.
- NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_assertion description "[Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822935.RAQU8T2yPm7tr-KI1cIQGEQ9G41ykfFYgypN62B6XLx_E130_provenance.